Cart
sales@molnova.com
ARRY-382
CAS No. 1313407-95-2
ARRY-382( ARRY382 )
Catalog No. M28026 CAS No. 1313407-95-2
ARRY-382 is a highly selective oral inhibitor of CSF-1R with an IC50 of 9 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 275 | In Stock |
|
| 10MG | 432 | In Stock |
|
| 25MG | 660 | In Stock |
|
| 50MG | 886 | In Stock |
|
| 100MG | 1144 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameARRY-382
-
NoteResearch use only, not for human use.
-
Brief DescriptionARRY-382 is a highly selective oral inhibitor of CSF-1R with an IC50 of 9 nM.
-
DescriptionARRY-382 is a highly selective oral inhibitor of CSF-1R with an IC50 of 9 nM.
-
In Vitro——
-
In Vivo——
-
SynonymsARRY382
-
PathwayTyrosine Kinase
-
TargetCSF1R
-
RecptorPDE10A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1313407-95-2
-
Formula Weight564.68
-
Molecular FormulaC32H36N8O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1cccc(Cn(c2ccc3)nc(C4CC4)c2c3NC(c2cnc3n2ccc(OCCN2CCN(C)CC2)c3)=O)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hamaguchi W, et al. Synthesis and in vivo evaluation of novel quinoline derivatives as phosphodiesterase 10A inhibitors. Chem Pharm Bull (Tokyo). 2014;62(12):1200-1213.
molnova catalog
related products
-
cFMS Receptor Inhibi...
cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
-
Emactuzumab
Emactuzumab(RG 7155) is a monoclonal antibody against colony-stimulating factor-1 receptor targeting tumor-associated macrophages (TAMs) Emactuzumab has antitumor activity and inhibits activation of colony-stimulating factor 1 receptor (CSF1R) Emactuzumab has a high affinity for CSF-1R with a Ki value of 0.2 nM.
-
Mavrilimumab
Mavrilimumab (CAM 3001) is a monoclonal antibody with antiviral activity that targets the α subunit of the granulocytic-macrophage colony-stimulating factor (GM-CSF) receptor, inhibiting downstream intracellular GM-CSF signaling.
